Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
National Cancer Institute (NCI),Children's Oncology Group
Scientific Title
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma